Summary of clinical results

DUCRAY
Kertyol PSO Concentré

Tolerance and efficacy of KERTYOL PSO concentrate

Tolerance and efficacy of KERTYOL PSO concentrate used alone in mild to moderate plaque psoriasis, under dermatological control

Population

55 adult subjects with mild to moderate plaque psoriasis on the body and/or scalp (PASI < 10 and/or scalp area affected between 10% and 50%) 

 

Application of KERTYOL PSO concentrate

  • Intensive treatment phase: Application twice a day to plaques for 4 weeks 
  • Maintenance phase: Application twice a week to areas affected by plaques for 4 weeks 

 

Evaluation criteria

  • Evaluation of pruritus intensity (NRS scale)
  • Clinical evaluation of plaque induration (score from 0 to 4)
  • Skin tolerance, under dermatological control

Result

  • From 8 days, significant decrease in pruritus sensations
EN-Kertyol PSO Concentré · Évolution de prurit.png
  • After 1 month, significant decrease of -43% in the induration of plaques
  • Significant results on plaque induration maintained during the maintenance phase (D57)
EN-Kertyol PSO Concentré · Évolution de l'induration.png
  • Good skin tolerance on the body and scalp
EN-Kertyol PSO Concentré · Efficacité.png

Conclusion

  • Relief of psoriasis-related pruritus and reduction in plaque induration
  • Good skin tolerance

More summaries of clinical results

  • Psoriasis
Tolerance and efficacy of KERTYOL PSO shampoo
DUCRAY
Tolerance and efficacy of KERTYOL PSO Rebalancing treatment shampoo used alone in mild to moderate psoriasis of the scalp, under dermatological control